US Airways Is on a ...
Health Care: Drugs
OxiGene Inc. (OXGN: NASDAQ)
$3.23 -0.02 | -0.62%
05/21/13 - 03:59 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 5,659 | 5,659 | 5,659 | 0 | 0 | 18,148 | 18,148 |
| Shares Bought | 5,659 | 5,659 | 5,659 | 0 | 0 | 18,148 | 18,148 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 223,576 | 223,398 | 10,273 | 1.39M | 1.39M | 3.09M | 3.09M |
| Shares Bought | 217,502 | 217,357 | 5,680 | 1.37M | 1.37M | 2.75M | 2.80M |
| Shares Sold | 13,603 | 733 | 22,065 | 8.26M | 8.26M | 8.25M | 8.25M |
Portfolios with OXGN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorSmall-Cap Stocks in Danger ...
- UserMy Portfolio
- UserMy Portfolio
- Contributor5 Drug Stock Losers of 2010
- UserASCO 2010 Part 2
- UserBIN
- UserJBOND Portfolio 1
- UserASCO 2009 Nymph's Watch List.
Latest OXGN Headlines from TheStreet
- OXiGENE Reports First Quarter 2013 Financial Results 05.06.13 | 04:05 pm
- OXiGENE Announces Completion Of Enrollment Of ZYBRESTAT(R) Phase 2 Ovarian Cancer Trial 04.24.13 | 04:04 pm
- OXiGENE Announces First Quarter 2013 Earnings Conference Call And Webcast 04.24.13 | 06:04 am
- OXiGENE Announces $5 Million Private Placement 04.11.13 | 08:04 am
- OXiGENE Announces Issuance Of Patent For Benzosuberenes, A Novel Anticancer Class Of Agents 03.20.13 | 04:03 pm
- OXiGENE Reports Full Year 2012 Financial Results 03.12.13 | 04:03 pm
- OXiGENE Announces Year-End 2012 Earnings Conference Call And Webcast 03.04.13 | 02:03 pm
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- OXiGENE Announces ZYBRESTAT(R) Plus Avastin(R) Continues To Be Well Tolerated In Second Interim Toxicity Analysis Of A Phase 2 Ovarian Cancer Trial 02.06.13 | 04:02 pm
- 3 Stocks Under $5 Making Big Moves 02.05.13 | 02:02 pm
Press Releases for OXGN
Partner Headlines for OXGN
- OXiGENE Announces Changes to Board of Directors - Benzinga 09.09.11 | 04:09 pm
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- ZYBRESTAT Results Suggest Improvement in Overall Survival in Phase 2/3 Study in Anaplastic Thyroid Cancer - Benzinga 06.06.11 | 04:06 pm
- Morning Market Movers - Benzinga 06.06.11 | 09:06 am
- 7 Big Movers That Investors Must Watch This Week - Seeking Alpha 06.06.11 | 08:06 am
- ASCO 2011: Opportunities for Biotech Investor Success and Failure - Seeking Alpha 05.02.11 | 09:05 am
- UPDATE 1-Oxigene reports positive data on cancer drug - Reuters 10.11.10 | 08:10 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- UPDATE 1-Oxigene says auditors raise going concern doubts - Reuters 03.19.10 | 08:03 am
- UPDATE 1-Oxigene to cut half the jobs, sees Q1 charge - Reuters 02.11.10 | 11:02 am
